Maraviroc
- Product NDC
- 68554-3080
- 11-digit product format
- 685543080
- Labeler code
- 68554
- Product ID
- 68554-3080_1c6b1759-8500-1fec-e063-6294a90afabc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Maraviroc
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Hetero Labs Limited
- Application
- ANDA203347
- Marketing category
- ANDA
- Marketing start
- 2022-02-06
- Substance
- MARAVIROC
- Active strength
- 300 mg/1
- Pharmacologic classes
- CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Maraviroc
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MARAVIROC | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | MD6P741W8A |
| Rxcui | 728223, 728225 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68554-3080-0 | Maraviroc | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68554-3080 | MARAVIROC (MARAVIROC) TABLET, FILM COATED [HETERO LABS LIMITED] | 1 | Current NDC, 1 package rows | 20240705_9db91945-127e-4bb6-970a-ff1e36dde658.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 68554-3080-0 | 68554308000 | 60 TABLET, FILM COATED in 1 BOTTLE (68554-3080-0) | 2022-02-06 | No | No | Historical |